BIOS Fund II, LP's Form 4 filing
IN8BIO, Inc. (INAB) · filed Dec 13, 2022
- Accession no.
- 0001104659-22-126432
- Filed
- Dec 13, 2022, 7:00 AM ET
- Trade date
- Dec 12, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $185.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BIOS Fund II, LPCIK 0001714576 | Director, 10% Owner |
| BIOS Fund II QP, LPCIK 0001716869 | Director, 10% Owner |
| BIOS Fund II NT, LPCIK 0001728851 | Director, 10% Owner |
| BIOS Incysus Co-Invest I, LPCIK 0001740029 | Director, 10% Owner |
| Fletcher Aaron G.L.CIK 0001789490 | Director, 10% Owner |
| BIOS Fund III NT, LPCIK 0001791910 | Director, 10% Owner |
| BIOS Fund III QP, LPCIK 0001791916 | Director, 10% Owner |
| BIOS Fund III, LPCIK 0001791917 | Director, 10% Owner |
| BIOS Advisors GP, LLCCIK 0001813844 | Director, 10% Owner |
| BIOS Capital Management, LPCIK 0001813845 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | PPurchaseAcquired | +9,214 | $2.48 | +$22,839.66 | 601,980 | Indirect | |
| Dec 12, 2022 | Common Stock | PPurchaseAcquired | +57,052 | $2.48 | +$141,420.5 | 3,727,597 | Indirect | |
| Dec 12, 2022 | Common Stock | PPurchaseAcquired | +8,735 | $2.48 | +$21,652.32 | 570,724 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.